LBF20115PG05: Difference between revisions

Latest revision as of 08:19, 21 October 2010

Upper classes: LB LBF

8-iso-13,14-dihydro-15-keto Prostaglandin F₂α

Structural Information
	(9α,11α)-Dihydroxy-15-oxo- (8β) -prost-cis-5-en-1-oic acid
	8-iso-13,14-dihydro-15-keto Prostaglandin F₂α (9α,11α)-Dihydroxy-15-oxo- (8β) -prost-5(Z)-en-1-oic acid

Formula	C20H34O5
Exact Mass	354.240624198
Average Mass	354.48096000000004
SMILES	`C(CCC(=O)CC[C@H]([C@@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC`
Physicochemical Information









	8-iso-13,14-dihydro-15-keto PGF2 alpha weakly has been reported to inhibit the U-46619 or collagen-induced platelet aggregation. Cranshaw_JH et al.


Spectral Information
Mass Spectra
UV Spectra
IR Spectra
NMR Spectra
Other Spectra
Chromatograms

Reported Metabolites, References

Biospecies	ID	Compound Name	Reference	Comment
n.a.	LBF20115PG05	See above.	Cranshaw_JH et al. 2001

@@ Line 1: / Line 1: @@
+{{Lipid/Header}}
 {{Hierarchy|{{PAGENAME}}}}
@@ Line 4: / Line 6: @@
 |LipidBank=XPR1789
 |LipidMaps=-
-|SysName=9a,11a-dihydroxy-15-oxo- (8b) -prost-5Z-en-1-oic acid
+|SysName=(9alpha,11alpha)-Dihydroxy-15-oxo- (8beta) -prost-cis-5-en-1-oic acid
-|Common Name=&&8-iso-13,14-dihydro-15-keto Prostaglandin F_2alpha&&9a,11a-dihydroxy-15-oxo- (8b) -prost-5Z-en-1-oic acid&&
+|Common Name=&&8-iso-13,14-dihydro-15-keto Prostaglandin F_2 alpha&&(9alpha,11alpha)-Dihydroxy-15-oxo- (8beta) -prost-5(Z)-en-1-oic acid&&
+|Source=
+|Chemical Synthesis=
+|Metabolism=
+|Biological Activity=8-iso-13,14-dihydro-15-keto PGF2 alpha  weakly has been reported to inhibit the U-46619 or collagen-induced platelet aggregation.[[Reference:Cranshaw_JH:Evans_TW:Mitchell_JA:,Br. J. Pharmacol.,2001,132,1699|{{RelationTable/GetFirstAuthor|Reference:Cranshaw_JH:Evans_TW:Mitchell_JA:,Br. J. Pharmacol.,2001,132,1699}}]]
 }}
+{{Lipid/Footer}}